Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 83

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

368	$NVLX Nuvilex Accelerates Development of	stocklegend	02/06/2014 12:58:49 PM
367	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/06/2014 12:32:11 PM
366	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/06/2014 11:42:05 AM
365	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/06/2014 10:43:10 AM
364	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/06/2014 10:22:41 AM
363	Interesting stock. Definitely on my watch list.	James719	02/06/2014 9:55:31 AM
362	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/06/2014 9:53:42 AM
361	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/06/2014 9:29:38 AM
360	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/06/2014 9:05:14 AM
359	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/06/2014 8:48:13 AM
358	$NVLX Nuvilex Accelerates Development of	stocklegend	02/05/2014 3:43:23 PM
357	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/05/2014 2:07:50 PM
356	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/05/2014 1:20:08 PM
355	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/05/2014 12:06:02 PM
354	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/05/2014 10:55:10 AM
353	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/05/2014 10:08:45 AM
352	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/05/2014 9:36:19 AM
351	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/05/2014 9:31:08 AM
350	NVLX news:	stocklegend	02/05/2014 9:16:53 AM
349	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/05/2014 9:14:54 AM
348	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/05/2014 8:36:19 AM
347	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/04/2014 3:13:24 PM
346	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/04/2014 2:57:56 PM
345	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/04/2014 2:01:40 PM
344	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/04/2014 12:57:25 PM
343	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/04/2014 12:20:16 PM
342	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/04/2014 11:52:46 AM
341	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/04/2014 11:13:02 AM
340	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/04/2014 10:47:16 AM
339	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/04/2014 10:03:55 AM
338	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/04/2014 9:27:09 AM
337	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/04/2014 9:08:30 AM
336	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/04/2014 8:54:06 AM
335	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/03/2014 3:41:01 PM
334	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/03/2014 3:27:37 PM
333	$NVLX Nuvilex Accelerates Development of	stocklegend	02/03/2014 3:17:08 PM
332	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/03/2014 2:03:06 PM
331	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/03/2014 1:51:15 PM
330	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/03/2014 1:08:20 PM
329	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/03/2014 11:45:26 AM
328	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/03/2014 11:27:11 AM
327	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/03/2014 10:15:30 AM
326	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/03/2014 9:06:03 AM
325	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/03/2014 8:37:39 AM
324	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/31/2014 3:07:13 PM
323	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/31/2014 2:54:11 PM
322	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/31/2014 2:14:26 PM
321	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/31/2014 1:37:36 PM
320	$NVLX Nuvilex Accelerates Development of	stocklegend	01/31/2014 12:52:18 PM
319	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/31/2014 12:47:29 PM

Newer

Older

Recent Articles

• Unlocking Rare Spirits: Cask Cartel's Cyber Monday Savings
• Investors Get Involved in Edwards Lifesciences Class Action
• Celsius Holdings Faces Class Action Lawsuit Over Misconduct
• Investors Urged to Act as Flux Power Faces Legal Scrutiny
• Evolv Technologies: Firm Investigates Investor Claims
• Investors Alert: Investigating Claims Against Acadia Healthcare
• Investigation into WM Technology by Faruqi & Faruqi, LLP
• Iris Energy Investors Alerted: Legal Investigation Underway
• Faruqi & Faruqi Investigates iLearningEngines Investor Claims
• Investors Take Note: Faruqi & Faruqi Looks Into Xiao-I Claims
• Investigation of Lilium N.V. by Faruqi & Faruqi, LLP
• Unmissable Cyber Monday Deals on Monport Laser Machines
• Elanco Animal Health Takes Legal Action Over Misleading Claims
• Midnight Hub NFT Investors: Join the Class Action for Justice
• Zeta Global Holdings Faces Class Action Lawsuit: Key Details
• AB Pieno žvaigzdes Reports Growth in Nine-Month Sales for 2024
• Celebrate the Holidays with Capriotti's 25 Days of Deals
• Positive Growth Indicators in PRFoods' Latest Interim Report
• Wright Way Enterprises Secures Major IRS Cybersecurity Contract
• Amber DWM and iClick Interactive Merge for Enhanced Growth
• Banco Comercial Português Reports Nine-Month Financial Results
• iLearningEngines, Inc. Investors: Important Legal Update Ahead
• ADGM's Asset Management Remarkably Thrives in Recent Quarter
• Explore Your Options in the Iris Energy Limited Securities Case
• BioTalent Canada Triumphs as Leader in Inclusion and Diversity
• Maximizing Online Presence with Free Website Audits
• Exploring Cultural Exchange Through 'Liangzhu' Documentary
• EDF Secures €6 Billion Credit Facility to Boost ESG Commitments
• Journey Through China's Ethnic Treasures: A Cultural Odyssey
• Transforming Waste into Sustainable Energy: Innovations Ahead
• Investors Urged to Join Class Action Against Chipotle
• Vantage Drilling Secures $50 Million in Senior Secured Notes
• Primega Group Holdings Resolves Nasdaq Compliance Issues
• Exploring Culinary Delights at the China Supply Chain Show
• High Arctic Overseas Reports Q3 2024 Financial Highlights
• Grab Unmissable Offers Before Monport's Black Friday Ends
• Canadian Spirit Resources Highlights First Quarter Financials
• Innovation at the Expo: Where Sci-Fi Meets Reality
• Rakovina Therapeutics Reports Q3 Financial Progress and Innovations
• Innovative Transportation Concepts at the China Supply Chain Expo
• Exploring Hotpot Culture at the China International Supply Chain Expo
• CBC Group and Mubadala Form NeuroGen Pharma for Growth
• GVD Markets Launches Global Expansion with Unique Trading Solutions
• CBC Group and Mubadala Form NeuroGen Pharma in China Deal
• Hampton Financial Corporation Distributes Stock Options for Growth
• Tice Family Takes Stand for Journalist in Press Conference
• ProMortgage Expands Team With Four Experienced Professionals
• Unlock Seamless Communication with iFLYTEK's Smart Translator
• Investor Alert: Acadia Healthcare Class Action Insights
• O2Gold Expands Acquisition Plans for Quebec Aur Property